Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Loke

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
British Journal of Haematology|February 12, 2026
Prevention and management of febrile neutropenia in acute myeloid leukaemia and higher risk myelodysplastic syndrome: An international survey of current practiceAleece MacPhail, Justin Loke, Brett L Houston, et al.
Blood|June 10, 2025
An in vivo barcoded CRISPR-Cas9 screen identifies Ncoa4-mediated ferritinophagy as a dependence in Tet2-deficient hematopoiesisJustin Loke, Peter Geon Kim, Thuy T P Nguyen, et al.
Blood Advances|April 14, 2023
Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDSJustin Loke, Nicholas McCarthy, Aimee Jackson, et al.
Blood|January 12, 2012
Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)Oliver C Goodyear, Mike Dennis, Nadira Y Jilani, et al.
Cell Reports|July 28, 2015
Chronic FLT3-ITD Signaling in Acute Myeloid Leukemia Is Connected to a Specific Chromatin SignaturePierre Cauchy, Sally R James, Joaquin Zacarias-Cabeza, et al.
Cancer|May 25, 2022
Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemiaJustin Loke, Myriam Labopin, Charles Craddock, et al.
Cancer|April 6, 2024
Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human leucocyte antigen 10/10 or 9/10 unrelated donor: An Acute Leukemia Working Party European Society for Blood and Marrow Transplantation studyJustin Loke, Myriam Labopin, Charles Craddock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2020
Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid LeukemiaCharles Craddock, Aimee Jackson, Justin Loke, et al.
Cell Chemical Biology|February 11, 2026
Metabolic control of innate immune activation in TET2-mutant clonal hematopoiesisPeter Geon Kim, Christopher B Hergott, Aidan P Miller, et al.
British Journal of Haematology|June 12, 2023
Defective T-cell response to COVID-19 vaccination in acute myeloid leukaemia and myelodysplastic syndromesJustin Loke, Vinit Upasani, Charlotte Gaskell, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
British Journal of Haematology|February 12, 2026
Prevention and management of febrile neutropenia in acute myeloid leukaemia and higher risk myelodysplastic syndrome: An international survey of current practiceAleece MacPhail, Justin Loke, Brett L Houston, et al.
Blood|June 10, 2025
An in vivo barcoded CRISPR-Cas9 screen identifies Ncoa4-mediated ferritinophagy as a dependence in Tet2-deficient hematopoiesisJustin Loke, Peter Geon Kim, Thuy T P Nguyen, et al.
Blood Advances|April 14, 2023
Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDSJustin Loke, Nicholas McCarthy, Aimee Jackson, et al.
Blood|January 12, 2012
Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)Oliver C Goodyear, Mike Dennis, Nadira Y Jilani, et al.
Cell Reports|July 28, 2015
Chronic FLT3-ITD Signaling in Acute Myeloid Leukemia Is Connected to a Specific Chromatin SignaturePierre Cauchy, Sally R James, Joaquin Zacarias-Cabeza, et al.
Cancer|May 25, 2022
Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemiaJustin Loke, Myriam Labopin, Charles Craddock, et al.
Cancer|April 6, 2024
Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human leucocyte antigen 10/10 or 9/10 unrelated donor: An Acute Leukemia Working Party European Society for Blood and Marrow Transplantation studyJustin Loke, Myriam Labopin, Charles Craddock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2020
Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid LeukemiaCharles Craddock, Aimee Jackson, Justin Loke, et al.
Cell Chemical Biology|February 11, 2026
Metabolic control of innate immune activation in TET2-mutant clonal hematopoiesisPeter Geon Kim, Christopher B Hergott, Aidan P Miller, et al.
British Journal of Haematology|June 12, 2023
Defective T-cell response to COVID-19 vaccination in acute myeloid leukaemia and myelodysplastic syndromesJustin Loke, Vinit Upasani, Charlotte Gaskell, et al.
Pageof 3